Gvhd Prophylaxis: Novel Strategies And Future Directions

GvHD prophylaxis: novel strategies and future directions

Treating Acute GVHD With Novel Strategies

Future directions for the management of cGvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Current approaches to GvHD prophylaxis and treatment

VJHemOnc – Video Journal of Hematology & HemOnc

Future Directions and Unmet Needs in Chronic GvHD

Targeted Oncology

Evolution & goals of GvHD prophylaxis strategies

VJHemOnc – Video Journal of Hematology & HemOnc

Challenges associated with the use of novel GvHD therapies in clinical practice

VJHemOnc – Video Journal of Hematology & HemOnc

Future perspectives of ECP for GvHD treatment

Novel-Based Approaches and the Future of Acute GVHD

Novel prophylactic therapies available before and after transplantation to reduce the risk of GvHD

What are the current treatment recommendations for acute GvHD and the promotion of the GvL effect?

How might itacitinib prophylaxis impact haplo-HSCT outcomes in the future?

Acute GVHD: Grade, Risk, and Prophylaxis

In what setting is abatacept most effective as GvHD prophylaxis?

Promising strategies to prevent GvHD in high-risk patients

VJHemOnc – Video Journal of Hematology & HemOnc

Managing GvHD in patients undergoing SCT

VJHemOnc – Video Journal of Hematology & HemOnc

Advances in GvHD management and prophylaxis

VJHemOnc – Video Journal of Hematology & HemOnc

Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease

PeerView Oncology

Introduction to Chronic Graft-vs-Host Disease (GVHD) 2018

Prevention strategies for acute and chronic GVHD in patients who have undergone transplantation

VJHemOnc – Video Journal of Hematology & HemOnc